Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma

TP63 encodes TAp63, which is functionally similar to the tumor suppressor TP53, and ΔNp63, which lacks the transcription-activating domain of TAp63 and appears potently oncogenic in squamous cell carcinomas (SCCs). In this study, we developed an integrated CRISPR interference (CRISPRi) system to sel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Yoshida, Masakazu, Yokota, Etsuko, Sakuma, Tetsushi, Yamatsuji, Tomoki, Takigawa, Nagio, Ushijima, Toshikazu, Yamamoto, Takashi, Fukazawa, Takuya, Naomoto, Yoshio
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6044376/
https://ncbi.nlm.nih.gov/pubmed/30018747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25678
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados